| Holding | Country | Type | Rating |
|---|
| US Government | United States | Fixed Income | — | 15.4% |
| Philip Morris | United States | Equity | — | 3.0% |
| Astrazeneca | United Kingdom | Equity | — | 3.0% |
| Nestle | Switzerland | Equity | — | 2.3% |
| Broadcom | United States | Equity | — | 2.2% |
| Holding | Country | Type | Rating |
|---|
| UnitedHealth | United States | Equity | — | 2.1% |
| TSMC | Taiwan | Equity | — | 2.1% |
| Pfizer | United States | Equity | — | 2.0% |
| Government Of Germany | Germany | Fixed Income | — | 1.8% |
| Microsoft | United States | Equity | — | 1.8% |
| Sector |
|---|
| Equity | 66.8% | 100.0 |
| Energy | 4.3% | 6.5% |
| Materials | 2.2% | 3.3% |
| Industrials | 8.3% | 12.4% |
| Consumer discretionary | 5.5% | 8.2% |
| Consumer staples | 11.4% | 17.1% |
| Health care | 13.0% | 19.4% |
| Financials | 7.7% | 11.5% |
| Information technology | 10.5% | 15.7% |
| Communication services | 1.1% | 1.6% |
| Utilities | 1.4% | 2.0% |
| Real Estate | 1.5% | 2.3% |
| Fixed Income | 28.2% | 100.0 |
| Government | 23.3% | 82.7% |
| Corporate | 4.9% | 17.3% |
| Cash and equivalents | 5.0% | 100.0 |
| Name |
|---|
| North America | 59.9% |
| Europe | 22.8% |
| Emerging Markets | 6.2% |
| Japan | 4.2% |
| Asia Pacific ex Japan | 1.4% |
| Other | 0.5% |
| Cash & equivalents | 5.0% |